FiLM 2019: Programme


Day One: Tuesday 29th January


​Chair: Ian Young, President ACB, UK

0845

Welcome and opening remarks
Ian Young


Enhanced Healthcare - improving patient outcomes and accountable care

0900

Outcome based healthcare and laboratory medicine
Mike Hallworth, Consultant Biochemist, Royal Shrewsbury Hospital, Shrewsbury, UK

0930

Adding value to healthcare by improved utilisation of laboratory medicine
Gary Procop, Professor of Pathology and Chairman of the Department of Molecular Pathology, Cleveland Clinic, Cleveland, OH, US

1000

Using data to impact change
Bill Morice, President of Mayo Medical Laboratories, Departmental Chair for Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, US

1030

How Accountable Care Systems can improve the utilisation of laboratory medicine
Rick VanNess, Director, Product Development, Tricore Reference Laboratories, Albuquerque, New Mexico, US

1100

Break


The Future of the Pathology Workforce

1120

The workforce pressures facing pathology and what are the potential solutions
Jo Martin, President, Royal College of Pathologists, UK

1145

Case study- Biomedical Scientist reporting in Cellular Pathology
Gerhard Van Schalkwyk, Consultant Histopathologist and Clinical Director, University
Hospitals of Derby and Burton, UK

1200

Using data to support workforce planning in Haematology
Mark Bishton, Consultant Haematologist, Nottingham University Hospitals, UK

1215

The expanding roles of Clinical Scientists
Gwyn McCreanor, Consultant Clinical Biochemist and Clinical Director, Kettering General Hospital Foundation Trust, Kettering, UK

1230

Panel discussion: How do we evolve to ensure a sustainable future pathology workforce

1300

Lunch


Getting it Right First Time

Getting It Right First Time is a national programme that aims to improve the quality of care within the NHS by reducing unwarranted variations. The GIRFT team will visit Trusts reviewing with them peer-related data and by sharing examples of best practice the aim is to improve patient outcomes and deliver cost effective care.
This session will be led by the GIRFT Pathology Clinical Leads to give an outline of the programme roll-out:


1400

Cellular Pathology
Simon Knowles, Consultant Cellular Pathologist, Royal Devon & Exeter NHS Foundation Trust, UK

1415

Microbiology
Tom Lewis, Consultant Microbiologist, North Devon Healthcare NHS Trust, UK

1430

Haematology
Marion Wood, Consultant Haematologist, UK

1445

Biochemistry
Martyn Myers, Consultant Clinical Biochemist, Royal Preston Hospital, UK

1500

GIRFT panel discussion

1540

Break


Increased NHS Funding – what are the priorities for investment in Laboratory Medicine?
What will the government’s proposal for the NHS to receive increased funding of £20.5bn in real terms per year by the end of the 5 years mean for laboratory services?

1600

The industry perspective
Doris-Ann Williams, CEO, BIVDA

1610

The Royal College of Pathologists perspective
Jo Martin, President, Royal College of Pathologists

1620

The Association for Clinical Biochemistry and Laboratory Medicine perspective
Ian Young, President, ACB

1630

Panel discussion- Increased NHS Funding
Panel members: Doris-Ann Williams, Jo Martin, Ian Young and GIRFT Leads

1710

Closing remarks
Ian Young

1730

Close

© Copyright The Association for Clinical Biochemistry and Laboratory Medicine
The Association for Clinical Biochemistry and Laboratory Medicine, 130-132 Tooley Street LONDON SE1 2TU
Tel: 020 7403 8001 Fax: 020 7403 8006